Craig C. Hopkinson
CIK 1730048 · EVP R&D, Chief Medical Officer · last filed 2026-06-01
Craig C. Hopkinson is an EVP R&D, Chief Medical Officer who has filed 54 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing, for ALKS, was dated Jun 1, 2026. Across all open-market trades the lifetime net is −$23.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.83M
2
54
-$23.42M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALKS | EVP R&D, Chief Medical Officer | 86,389 | $44.28 | $3.83M | -$23.42M | 52 | 2026-06-01 |
| ALBIREO PHARMA, INC. (ALBO) Delisted | Director | 10,495 | $44.15 | $463.4K | $0 | 2 | 2023-03-02 |
Recent Filings
54 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-01 | ALKS | Mixed | −4,000 | -$278.3K | EDGAR |
| 2026-05-01 | ALKS | Mixed | −4,000 | -$203.9K | EDGAR |
| 2026-04-01 | ALKS | Mixed | −4,000 | -$222.9K | EDGAR |
| 2026-03-04 | ALKS | Mixed | −4,000 | -$170.8K | EDGAR |
| 2026-02-27 | ALKS | Mixed | +3,817 | -$93.7K | EDGAR |
| 2026-02-25 | ALKS | Mixed | +4,275 | -$109.9K | EDGAR |
| 2026-02-20 | ALKS | Mixed | +9,659 | -$221.2K | EDGAR |
| 2026-02-06 | ALKS | Mixed | +17,898 | -$250.1K | EDGAR |
| 2026-02-02 | ALKS | Mixed | −4,000 | -$208.7K | EDGAR |
| 2026-01-08 | ALKS | Mixed | — | -$53.3K | EDGAR |